Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPiTA trial of 13-valent pneumococcal conjugate vaccine in older adults
2008-000023-26Phase 4Completed
- Sponsor
- Wyeth
- Start
- May 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial in pneumococcal disease, community-acquired pneumonia (CAP) and invasive pneumococcal disease (IPD) comparing 13-valent pneumococcal conjugate vaccine with Placebo (2 arms). Primary endpoints: Vaccine-type pneumococcal community-acquired pneumonia and Nonbacteremic vaccine-type pneumococcal community-acquired pneumonia. Started May 2008; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal diseasecommunity-acquired pneumonia (CAP)invasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on 2008-000023-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000023-26.